CisplatinGrade I myelosuppression: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2025年 / 2044卷 / 1期

关键词：

D O I：

10.1007/s40278-025-75763-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：97 / 97

相关论文

共 50 条

[31] Multiple drugsMucositis and myelosuppression: case report
Reactions Weekly, 2018, 1691 (1) : 198 - 198
[32] AzathioprineAnagen effluvium and myelosuppression: case report
Reactions Weekly, 2019, 1746 (1) : 42 - 42
[33] AntineoplasticsHaemophagocytic lymphohistiocytosis and myelosuppression: case report
Reactions Weekly, 2021, 1881 (1) : 26 - 26
[34] HydroxycarbamideAnaemia secondary to myelosuppression: case report
Reactions Weekly, 2020, 1819 (1) : 137 - 137
[35] RosiglitazonePancytopenia, myelosuppression and exophthalmos: case report
Reactions Weekly, 2010, 1302 (1) : 42 - 42
[36] AntineoplasticsDrug resistance and myelosuppression: case report
Reactions Weekly, 2022, 1890 (1) : 42 - 42
[37] PalbociclibNeutropenia, thrombocytopenia and myelosuppression: case report
Reactions Weekly, 2019, 1772 (1) : 261 - 261
[38] RifampicinResistance to rifampicin and myelosuppression: case report
Reactions Weekly, 2022, 1928 (1) : 321 - 321
[39] Capecitabine/oxaliplatinEnterocolitis and myelosuppression: case report
Reactions Weekly, 2022, 1893 (1) : 82 - 82
[40] Gemcitabine/paclitaxelPeripheral neuropathy and myelosuppression: case report
Reactions Weekly, 2018, 1725 (1) : 157 - 157

← 1 2 3 4 5 →